206 related articles for article (PubMed ID: 38136437)
21. Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder.
Shorning BY; Griffiths D; Clarke AR
PLoS One; 2011 Jan; 6(1):e16209. PubMed ID: 21283818
[TBL] [Abstract][Full Text] [Related]
22. Specific deletion of LKB1/
George JW; Patterson AL; Tanwar PS; Kajdacsy-Balla A; Prins GS; Teixeira JM
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3445-3450. PubMed ID: 28289208
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma.
Li M; Sun H; Song L; Gao X; Chang W; Qin X
Oncol Lett; 2012 Dec; 4(6):1213-1218. PubMed ID: 23205120
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanism of LKB1 in the invasion and metastasis of colorectal cancer.
Chen Y; Liu Y; Zhou Y; You H
Oncol Rep; 2019 Feb; 41(2):1035-1044. PubMed ID: 30483811
[TBL] [Abstract][Full Text] [Related]
25. LKB1 deletion with the RIP2.Cre transgene modifies pancreatic beta-cell morphology and enhances insulin secretion in vivo.
Sun G; Tarasov AI; McGinty JA; French PM; McDonald A; Leclerc I; Rutter GA
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1261-73. PubMed ID: 20354156
[TBL] [Abstract][Full Text] [Related]
26. Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers.
Herrmann JL; Byekova Y; Elmets CA; Athar M
Cancer Lett; 2011 Jul; 306(1):1-9. PubMed ID: 21450399
[TBL] [Abstract][Full Text] [Related]
27. The tumor suppressor kinase LKB1: lessons from mouse models.
Ollila S; Mäkelä TP
J Mol Cell Biol; 2011 Dec; 3(6):330-40. PubMed ID: 21926085
[TBL] [Abstract][Full Text] [Related]
28. Systemic Deficiency of PTEN Accelerates Breast Cancer Growth and Metastasis.
Chen J; Sun J; Wang Q; Du Y; Cheng J; Yi J; Xie B; Jin S; Chen G; Wang L; Wang X; Wei H
Front Oncol; 2022; 12():825484. PubMed ID: 35372075
[TBL] [Abstract][Full Text] [Related]
29. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.
Mehenni H; Lin-Marq N; Buchet-Poyau K; Reymond A; Collart MA; Picard D; Antonarakis SE
Hum Mol Genet; 2005 Aug; 14(15):2209-19. PubMed ID: 15987703
[TBL] [Abstract][Full Text] [Related]
30. The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.
Shukuya T; Yamada T; Koenig MJ; Xu J; Okimoto T; Li F; Amann JM; Carbone DP
J Thorac Oncol; 2019 Jun; 14(6):1061-1076. PubMed ID: 30825612
[TBL] [Abstract][Full Text] [Related]
31. Unravelling the connection between metabolism and tumorigenesis through studies of the liver kinase B1 tumour suppressor.
Shackelford DB
J Carcinog; 2013 Aug; 12():16. PubMed ID: 24082825
[TBL] [Abstract][Full Text] [Related]
32. ATM-mediated PTEN phosphorylation promotes PTEN nuclear translocation and autophagy in response to DNA-damaging agents in cancer cells.
Chen JH; Zhang P; Chen WD; Li DD; Wu XQ; Deng R; Jiao L; Li X; Ji J; Feng GK; Zeng YX; Jiang JW; Zhu XF
Autophagy; 2015; 11(2):239-52. PubMed ID: 25701194
[TBL] [Abstract][Full Text] [Related]
33. Novel mutations and role of the LKB1 gene as a tumor suppressor in renal cell carcinoma.
Yalniz Z; Tigli H; Tigli H; Sanli O; Dalay N; Buyru N
Tumour Biol; 2014 Dec; 35(12):12361-8. PubMed ID: 25179843
[TBL] [Abstract][Full Text] [Related]
34. Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells.
Nishimura S; Yashiro M; Sera T; Yamamoto Y; Kushitani Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Okuno T; Murakami Y; Ohira M
Carcinogenesis; 2020 Nov; 41(11):1616-1623. PubMed ID: 32236518
[TBL] [Abstract][Full Text] [Related]
35. The role of the Lkb1/AMPK pathway in hematopoietic stem cells and Leukemia.
Saito Y; Nakada D
Crit Rev Oncog; 2014; 19(5):383-97. PubMed ID: 25404152
[TBL] [Abstract][Full Text] [Related]
36. The PTEN tumor suppressor gene and its role in lymphoma pathogenesis.
Wang X; Huang H; Young KH
Aging (Albany NY); 2015 Dec; 7(12):1032-49. PubMed ID: 26655726
[TBL] [Abstract][Full Text] [Related]
37. Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer.
King CT; Matossian MD; Savoie JJ; Nguyen K; Wright MK; Byrne CE; Elliott S; Burks HE; Bratton MR; Pashos NC; Bunnell BA; Burow ME; Collins-Burow BM; Martin EC
Front Mol Biosci; 2022; 9():847505. PubMed ID: 35755802
[TBL] [Abstract][Full Text] [Related]
38. Liver kinase B1/adenosine monophosphate-activated protein kinase signaling axis induces p21/WAF1 expression in a p53-dependent manner.
Ma Q; Xiao P; Sun L; Wang J; Zhong D
Oncol Lett; 2018 Jul; 16(1):1291-1297. PubMed ID: 29963200
[TBL] [Abstract][Full Text] [Related]
39. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.
Kinoshita H; Hayakawa Y; Konishi M; Hata M; Tsuboi M; Hayata Y; Hikiba Y; Ihara S; Nakagawa H; Ikenoue T; Ushiku T; Fukayama M; Hirata Y; Koike K
J Pathol; 2019 Jan; 247(1):35-47. PubMed ID: 30168144
[TBL] [Abstract][Full Text] [Related]
40. PI3K/PTEN signaling in angiogenesis and tumorigenesis.
Jiang BH; Liu LZ
Adv Cancer Res; 2009; 102():19-65. PubMed ID: 19595306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
